儿童耐药结核病诊治研究进展

doi:10.19983/j.issn.2096-8493.20220106

结核与肺部疾病杂志 ›› 2022, Vol. 3 ›› Issue (5): 402-404.doi: 10.19983/j.issn.2096-8493.20220106

儿童耐药结核病诊治研究进展

郑惠文, 李飞娜, 申晨()

国家儿童医学中心,国家呼吸系统疾病临床医学研究中心,教育部儿科重大疾病研究重点实验室/首都医科大学附属北京儿童医院,北京市儿科研究所,儿童呼吸道感染性疾病研究北京市重点实验室,呼吸疾病研究室,北京 100045

收稿日期:2022-06-23 出版日期:2022-10-20 发布日期:2022-10-14
通信作者: 申晨 E-mail:shenchen1110@126.com
基金资助:
北京市自然科学基金(7202043);北京市自然科学基金(7224328)

Research progress of diagnosis and treatment of drug resistant tuberculosis in children

Zheng Huiwen, Li Feina, Shen Chen()

National Center for Children’s Health, National Clinical Research Center for Respiratory Diseases, Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing Children’s Hospital, Capital Medical University, Beijing Pediatric Research Institute, Laboratory of Respiratory Diseases, Beijing Key Laboratory of Pediatric Respiratory Infection Diseases, Beijing 100045, China

Received:2022-06-23 Online:2022-10-20 Published:2022-10-14
Contact: Shen Chen E-mail:shenchen1110@126.com
Supported by:
Beijing Natural Science Foundation(7202043);Beijing Natural Science Foundation(7224328)

摘要/Abstract

摘要：

耐药结核病是严重危害儿童健康的重要疾病之一。儿童结核病患者临床症状不典型、细菌载量低、病原学难以确诊,在诊断和治疗上均存在较大困难,对结核病防控构成了严重的威胁。作者对儿童耐药结核病诊断与治疗最新进展进行综述。

关键词: 结核, 儿童, 结核,抗多种药物性, 综述文献(主题)

Abstract:

Drug resistant tuberculosis is one of the major health issues harming health of children. Significant difficulties existed in diagnosis and treatment of tuberculosis in child patients due to atypical clinical symptoms, low bacterial load, and difficulties in etiological diagnosis, which pose a serious threat to tuberculosis prevention and control. This paper reviews the latest progress in the diagnosis and treatment of drug resistant tuberculosis in children.

Key words: Tuberculosis, Children, Tuberculosis, multidrug-resistant, Review literature as topic

中图分类号:

R529.9

郑惠文, 李飞娜, 申晨. 儿童耐药结核病诊治研究进展[J]. 结核与肺部疾病杂志, 2022, 3(5): 402-404. doi: 10.19983/j.issn.2096-8493.20220106

Zheng Huiwen, Li Feina, Shen Chen. Research progress of diagnosis and treatment of drug resistant tuberculosis in children[J]. Journal of Tuberculosis and Lung Disease, 2022, 3(5): 402-404. doi: 10.19983/j.issn.2096-8493.20220106

参考文献 21

[1]	Jenkins HE, Tolman AW, Yuen CM, et al. Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. Lancet, 2014, 383(9928):1572-1579. doi: 10.1016/S0140-6736(14)60195-1. doi: 10.1016/S0140-6736(14)60195-1 pmid: 24671080
[2]	Jenkins HE, Yuen CM. The burden of multidrug-resistant tuberculosis in children. Int J Tubere Lung Dis, 2018, 22(5):3-6. doi: 10.5588/ijtld.17.0357. doi: 10.5588/ijtld.17.0357
[3]	Dodd PJ, Sismanidis C, Seddon JA. Global burden of drug resistant tuberculosis in children: a mathematical modeling study. Lancet Infect Dis, 2016, 16(10):1193-1201. doi: 10.1016/S1473-3099(16)30132-3. doi: 10.1016/S1473-3099(16)30132-3 URL
[4]	Song WM, Li YF, Liu YX, et al. Drug-Resistant Tuberculosis Among Children: A Systematic Review and Meta-Analysis. Front Public Health, 2021, 9:721817. doi: 10.3389/fpubh.2021.721817. doi: 10.3389/fpubh.2021.721817
[5]	World Health Organization. Global tuberculosis report 2021. Gevena: World Health Organization, 2021.
[6]	Jiao WW, Liu ZG, Han R, et al. Prevalence of drug resistant Mycobacterium tuberculosis among children in China. Tuberculosis (Edinb), 2015, 95(3): 315-320. doi: 10.1016/j.tube.2015.02.041. doi: 10.1016/j.tube.2015.02.041 URL
[7]	Tao NN, He XC, Zhang XX, et al. Drug-Resistant Tuberculosis among Children, China, 2006-2015. Emerg Infect Dis, 2017, 23(11):1800-1805. doi: 10.3201/eid2311.170234. doi: 10.3201/eid2311.170234 URL
[8]	Wang T, Dong F, Li QJ, et al. Clinical and Drug Resistance Characteristics of New Pediatric Tuberculosis Cases in Northern China. Microb Drug Resis, 2018, 24(9):1397-1403. doi: 10.1089/mdr.2017.0382. doi: 10.1089/mdr.2017.0382 URL
[9]	Xu YH, Li QF, Zhu M, et al. The epidemiological characteristics and profile of drug-resistant tuberculosis among children with tuberculosis in Sichuan, China, 2015-2018: A retrospective study. Medicine, 2020, 99(43):e22608. doi: 10.1097/MD.0000000000022608. doi: 10.1097/MD.0000000000022608
[10]	World Health Organization. Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children, WHO Policy update. Geneva: World Health Organization, 2014.
[11]	World Health Organization. WHO Meeting Report of a Technical Expert Consultation:Non-inferiority analysis of Xpert MTB/RIF Ultra compared to Xpert MTB/RIF. Geneva: World Health Organization, 2017.
[12]	Horne DJ, Kohli M, Zifodya JS, et al. Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults. Database Syst Rev, 2019, 6:CD009593. doi: 10.1002/14651858.CD009593.pub4. doi: 10.1002/14651858.CD009593.pub4
[13]	Wsttal C, Raveendran R. Newer Diagnostic Tests and their Application in Pediatric TB. Indian J Pediatr, 2019, 86(5):441-447. doi: 10.1007/s12098-018-2811-0. doi: 10.1007/s12098-018-2811-0 pmid: 30628039
[14]	吕纯阳, 罗晶晶, 石华, 等. 儿童结核病的实验室诊断现状与进展. 中国防痨杂志, 2020, 42(2):178-184. doi: 10.3969/j.issn.1000-6621.2020.02.018. doi: 10.3969/j.issn.1000-6621.2020.02.018
[15]	焦伟伟. 儿童结核病分子生物学诊断方法研究进展. 结核与肺部疾病杂志, 2021, 2(1):69-72. doi: 10.3969/j.issn.2096-8493.2021.01.015. doi: 10.3969/j.issn.2096-8493.2021.01.015
[16]	Schaaf HS, Garcis-Prats AJ, Hesseling AC, et al. Managing multidrug-resistant tuberculosis in children: review of recent developments. Curr Opin Infect Dis, 2014, 27(3):211-219. doi: 10.1097/QCO.0000000000000062. doi: 10.1097/QCO.0000000000000062 pmid: 24751893
[17]	杨丹丹, 陈军华. 儿童耐药结核病诊治进展. 国际儿科学杂志, 2022, 49(2):109-113. doi: 10.3760/cma.j.issn.1673-4408.2022.02.009. doi: 10.3760/cma.j.issn.1673-4408.2022.02.009
[18]	Sun Y, Gao L, Xia H, et al. Accuracy of molecular diagnostic tests for drug resistant tuberculosis detection in China: a systematic review. Int J Tuberc Lung Dis, 2019, 23(8):931-942. doi: 10.5588/ijtld.18.0550. doi: 10.5588/ijtld.18.0550 pmid: 31533884
[19]	邓建军, 肖国光, 万朝敏, 等. 基因芯片技术与涂片培养技术对诊断儿童结核病的比较研究. 四川大学学报(医学版), 2013, 44(3):429-431. doi: 10.13464/j.scuxbyxb.2013.03.006. doi: 10.13464/j.scuxbyxb.2013.03.006
[20]	焦伟伟, 申阿东. 儿童结核病药物治疗现状及进展. 中华实用儿科临床杂志, 2020, 5(35):753-758. doi: 10.3760/cmn.j.cn101070-20200525-00883. doi: 10.3760/cmn.j.cn101070-20200525-00883
[21]	World Health Organization. WHO treatment guidelines for multidrug and rifampicin resistant tuberculosis,2018 update. Geneva: World Health Organization, 2018:17-23.

儿童耐药结核病诊治研究进展

Research progress of diagnosis and treatment of drug resistant tuberculosis in children

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 21

相关文章 15

编辑推荐

Metrics

本文评价

友情链接

[1]	陈豪, 申晨. 重视儿童结核病的鉴别诊断[J]. 结核与肺部疾病杂志, 2022, 3(5): 353-357.
[2]	仵倩红, 甘昭平. 重视腹腔结核的早诊早治[J]. 结核与肺部疾病杂志, 2022, 3(5): 358-359.
[3]	李妍, 韩彤昕, 朴玉蓉, 毛华伟. 儿童关节结核误诊为幼年特发性关节炎五例临床分析[J]. 结核与肺部疾病杂志, 2022, 3(5): 364-370.
[4]	刘鑫, 郭乐, 李军孝, 陈其亮, 仵倩红. 不同类型腹腔结核Ⅰ期手术疗效分析[J]. 结核与肺部疾病杂志, 2022, 3(5): 371-376.
[5]	孙秀利, 李亚波, 缑良芝, 任倍莹, 仵倩红. 宫腹腔镜检查在不孕女性疑似生殖器结核的应用价值[J]. 结核与肺部疾病杂志, 2022, 3(5): 377-381.
[6]	李静, 梁亚萍, 邹远妩, 张思琪, 郑见宝, 仵倩红. GeneXpert MTB/RIF检测粪便标本对肠结核的诊断价值[J]. 结核与肺部疾病杂志, 2022, 3(5): 382-387.
[7]	陈子丹, 毛翎. 人造石相关矽肺合并肺结核与非结核分枝杆菌肺病28例临床分析[J]. 结核与肺部疾病杂志, 2022, 3(5): 388-393.
[8]	陈涛, 杨星, 陈连勇, 陈金瓯, 茹浩浩, 唐顺定, 许琳. 云南省某县级基层结核病定点医院职工结核感染控制知信行调查分析[J]. 结核与肺部疾病杂志, 2022, 3(5): 394-401.
[9]	张春华, 陈伟. 儿童结核病流行现状与经济负担研究进展[J]. 结核与肺部疾病杂志, 2022, 3(5): 405-409.
[10]	刘原园, 李璐, 吴托雅, 鲁洁. 结核分枝杆菌Mce4蛋白家族研究进展[J]. 结核与肺部疾病杂志, 2022, 3(5): 415-419.
[11]	刘琳琳, 王秀芬, 姜游力, 桂敏, 陈敬芳. 肺结核后肺病患者肺康复训练的应用进展[J]. 结核与肺部疾病杂志, 2022, 3(5): 420-424.
[12]	刘芳, 马渝燕, 饶小春, 孟辰芳, 潘跃娜, 焦安夏. 氩等离子凝固术联合冷冻治疗儿童淋巴结瘘型气管支气管结核一例[J]. 结核与肺部疾病杂志, 2022, 3(5): 425-428.
[13]	卢水华. 关注结核病共患病已成为公共卫生的需要[J]. 结核与肺部疾病杂志, 2022, 3(4): 255-260.
[14]	古力米娜·阿布力米提, 麦维兰江·阿不力米提, 地尔木拉提·吐逊, 刘振江, 何懿, 苏伟, 欧喜超. 2021年喀什地区肺结核患者利福平耐药影响因素分析[J]. 结核与肺部疾病杂志, 2022, 3(4): 269-273.
[15]	杨震, 雷囡, 赵飞, 何艳萍, 林娜, 张治国. 北京市昌平区高等院校新生结核分枝杆菌潜伏感染状况调查及潜伏感染者预防性治疗效果分析[J]. 结核与肺部疾病杂志, 2022, 3(4): 274-280.